wtx212
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2022 (NCT05707325)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- ErythrocyteSupplementation
Erythrocyte supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07269899 | Phase 1 | Nov 25, 2025 | Government of China, Sun Yat-Sen University |
| NCT06106152 | Early Phase 1 (Phase 1) | Nov 27, 2023 | Government of China, Zhejiang University |
| NCT05707325 | Phase 1 | Oct 31, 2022 | Government of China, Zhejiang University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 3 | 1 | 1 | 2022 |
| Zhejiang University | Academic/Hospital | 2 | 1 | 1 | 2022 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1